PhytoHealth Corporation is a Taiwan company principally engaged in the research, development and manufacture of new botanical drugs. The Company's main products include western medicines, Chinese herbal medicines, cosmetics, Class B drugs and supplementary food. The Company also provides pharmaceutical consulting services. The Company distributes its products in domestic market and to overseas markets.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
06/11/26	TWD 10.60	-2.30%	408,366
05/11/26	TWD 10.85	-2.69%	246,144
04/11/26	TWD 11.15	+0.45%	237,352
03/11/26	TWD 11.10	-2.63%	263,146
02/11/26	TWD 11.40	+1.33%	162,697

End-of-day quote Taiwan S.E.

More quotes

End-of-day quote Taiwan S.E. 06/11/2026			5-day change	1st Jan Change
10.60 ^TWD	-2.30%		-5.78%	-21.48%

05/08	PhytoHealth Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
03/06	PhytoHealth's Revenue Rises 18% in May	MT

Market Cap	2.11B 64.22M 57.59M 52.64M 48.05M 90.53M 6.04B 93.38M 634M 253M 3.22B 241M 236M 10.17B	P/E 2024	-45.4x	P/E 2025	-46.1x
Enterprise Value	1.06B 32.22M 28.9M 26.41M 24.11M 45.42M 3.03B 46.85M 318M 127M 1.62B 121M 118M 5.1B	EV / Sales 2024	14.8x	EV / Sales 2025	12.1x
Free-Float	75.14%	Yield 2024 *	-	Yield 2025	-

05/08	PhytoHealth Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
03/06	PhytoHealth's Revenue Rises 18% in May	MT
12/05	PhytoHealth Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03/03	PhytoHealth Corporation Reports Earnings Results for the Full Year Ended December 31, 2025	CI
11/11	PhytoHealth Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
22/09/25	PhytoHealth Corporation(TWSE:4108) dropped from S&P Global BMI Index	CI
13/08/25	PhytoHealth Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
06/05/25	PhytoHealth, German Firm to Jointly Market Rectal Pain Drug in EU	MT
05/05/25	PhytoHealth Corporation Signs Letter of Intent with Aristo Pharma GmbH	CI
05/05/25	PhytoHealth Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
06/03/25	PhytoHealth Corporation Announces Resignation of Wang Der-Shan as Member of Audit Committee and Remuneration Committee	CI
06/03/25	PhytoHealth Corporation Announces Resignation of Wang Der-Shan as Independent Director	CI
27/02/25	PhytoHealth Corporation Reports Earnings Results for the Full Year Ended December 31, 2024	CI

09/08/22	PhytoHealth : BOD approve the 2022 second quarter consolidated financial report	PU
05/07/22	Phytohealth : is invited to Online Investor Conference held by KGI Securities	PU
24/05/22	PhytoHealth : Important resolutions of company's 2022 shareholders' meeting.	PU
08/04/22	PhytoHealth : Public announcement of the progress of company's committed items at the time when stock was listed on Taiwan Stock Exchange.	PU
09/03/22	PhytoHealth : Announcement of the financial information of February 2022	PU

PhytoHealth Corporation Stock

Stocks

4108

TW0004108006

Pharmaceuticals

Valuation: PhytoHealth Corporation

Chart: PhytoHealth Corporation

Latest news: PhytoHealth Corporation

Press Releases: PhytoHealth Corporation

Quotes and Performance

Price Extremes

Managers and Directors: PhytoHealth Corporation

Biopharmaceuticals

Financials

Company Profile

Quotes

1 day	-2.30%
1 week	-5.78%
Current month	-5.78%
1 month	-6.61%
3 months	-4.93%
6 months	-11.67%
Current year	-21.48%

1 week	10	11.45
1 month	10	12.25
Current year	10	15.25
1 year	10	15.25
3 years	10	24
5 years	10	25.25
10 years	10	41.05

Manager	Title	Age	Since
I Lin Lee CEO	Chief Executive Officer	-	13/06/2017
Chih Yuan Huang DFI	Director of Finance/CFO	-	11/05/2021
Teng Hsu Wang CTO	Chief Tech/Sci/R&D Officer	-	30/07/2021

Director	Title	Age	Since
Cheng Chia Li CHM	Chairman	-	10/06/2011
Yue Ju Lai BRD	Director/Board Member	-	16/03/2010
Yi Li Lee CHM	Chairman	55	26/05/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PHYTOHEALTH CORPORATION	-2.30%	-5.78%	-24.82%	-55.74%	64.22M
ELI LILLY AND COMPANY	-0.79%	-4.48%	+46.48%	+125.69%	1,206B
JOHNSON & JOHNSON	+1.43%	+1.11%	+48.05%	+83.05%	665B
ABBVIE INC.	+1.07%	-1.21%	+32.92%	+104.92%	515B
ROCHE HOLDING AG	-0.36%	-3.25%	+45.42%	+65.10%	381B
MERCK & CO., INC.	-0.14%	-1.87%	+70.06%	+41.09%	362B
NOVARTIS AG	-0.78%	-0.52%	+30.47%	+58.09%	307B
ASTRAZENECA PLC	-0.80%	-0.21%	+7.98%	+36.17%	289B
AMGEN INC.	+0.03%	-1.20%	+43.79%	+69.83%	249B
GILEAD SCIENCES, INC.	-0.41%	-2.22%	+40.43%	+107.03%	207B
Average	-0.31%	-2.09%	+34.08%	+63.52%	417.98B
Weighted average by Cap.	-0.04%	-1.96%	+42.71%	+88.11%

	2024	2025
Net sales	154M 4.68M 4.2M 3.84M 3.5M 6.6M 440M 6.81M 46.28M 18.45M 235M 17.58M 17.2M 742M	135M 4.1M 3.68M 3.36M 3.07M 5.79M 386M 5.97M 40.55M 16.17M 206M 15.41M 15.08M 650M
Net income	-73.5M -2.24M -2.01M -1.84M -1.68M -3.16M -211M -3.26M -22.15M -8.83M -112M -8.41M -8.23M -355M	-58.2M -1.78M -1.59M -1.46M -1.33M -2.5M -167M -2.58M -17.54M -6.99M -89.04M -6.66M -6.52M -281M
Net Debt	-1.06B -32.39M -29.05M -26.55M -24.23M -45.66M -3.04B -47.1M -320M -128M -1.62B -122M -119M -5.13B	-1.05B -32M -28.7M -26.23M -23.94M -45.11M -3.01B -46.53M -316M -126M -1.6B -120M -118M -5.07B